Eli Lilly Nears $2.5 Billion Deal to Acquire Scorpion Therapeutics

Eli Lilly and Company is reportedly finalizing a $2.5 billion acquisition of Scorpion Therapeutics, with a $1 billion upfront payment and up to $1.5 billion more based on performan...